BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
about
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarianAssociations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutationsNo evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees.Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based studyCurrent condition of genetic medicine for hereditary breast cancer.BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data.Mutational landscape of candidate genes in familial prostate cancerTumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancerGenotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.The 6q22.33 locus and breast cancer susceptibilityHereditary breast and ovarian cancer: new genes, new treatments, new concepts.Genetic architecture of prostate cancer in the Ashkenazi Jewish population.Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review.Germline BRCA1 mutations increase prostate cancer riskDo Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.Risk prediction models for familial breast cancer.An inherited NBN mutation is associated with poor prognosis prostate cancerRare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.Rapid progression of prostate cancer in men with a BRCA2 mutation.Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study.Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers.The role of the BRCA2 gene in susceptibility to prostate cancer revisitedGermline BRCA mutations denote a clinicopathologic subset of prostate cancer.The role of BRCA1 and BRCA2 in prostate cancer.Clinical stages in patients with primary and subsequent cancers based on the czech cancer registry 1976-2005Genetics and genomics of prostate cancer.Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.Skin cancer risk in BRCA1/2 mutation carriers.Stress management by autophagy: Implications for chemoresistance.Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.The clinical genetics of prostate cancer.Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms.Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers.Susceptibility loci associated with prostate cancer progression and mortality.The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.
P2860
Q24672251-46CB6FD6-34A0-4CDB-A0F3-BBC539B39603Q28386233-810156C1-FB5A-44F2-8281-2592A8F90FBEQ33454990-3EDE1A88-28BB-4EEE-9A60-84A8FC43D459Q33609681-94C90C86-AF9F-4212-B6A0-783F6558CCCFQ33858408-7472F1E5-A0BD-4945-BA63-06ACA1D2AA48Q33881971-F44FA108-CBF6-49AA-92F4-15293D722E91Q34079517-928C7F22-F7F8-4BF2-8AF6-180A62C8EEBDQ34109373-C54F1DEE-B418-4135-8EF4-FBC2878BD7F4Q34263742-DE7EAE89-6449-4AC7-BEC7-642D6223E6D9Q34475135-B290264A-447F-4312-B114-D6B270CEB2C2Q34858803-BC72C05F-35F2-4755-B263-B4CBF07D467AQ35019634-E722278F-5527-4322-A2B1-48AE3FBF0BF6Q35208177-B2B9ACD7-D56F-4C4E-A531-24558E1EF610Q35687632-3141ECBA-73C8-4E9B-BE6A-27FEBFA97D24Q35949522-D2525A11-775E-431F-A13D-1F3FA96AEE23Q36110947-17F26DCD-A877-4DCE-95F3-E59212B26589Q36359653-F104C3BC-49BC-4048-9A19-F2E03D64937DQ36430753-1A9D761A-704B-4ABB-9673-AC6BF9E7E685Q36594121-2B31D727-7177-4E1A-A583-012B56028F08Q36611191-27BD505B-D02E-4942-B862-0A914734F9ABQ36615665-61BEBB44-7ABC-4CB9-987C-A04C014331BAQ36785963-97ADA44C-2D0E-4BF6-BAE1-4C7FB0FDD0B8Q36909418-6A1B709A-271C-487D-A0D8-9637A65DDEDCQ36914269-B6140E81-B9EE-4097-9A28-B3060B9F8A09Q36924831-9160B1FF-43DD-4386-9F0F-6404F0480F30Q37019841-750E532A-88DE-4505-B191-08196C026D90Q37037789-62CC15AB-27CB-431F-9176-F606B85CC8EBQ37051847-B716189B-7E41-45FF-972A-CD6F5F8ED423Q37085413-BC218D05-4814-4CC0-80CE-660BB95A1CA1Q37195960-3CB8A503-4C59-487F-936F-577DF7A6E269Q37481918-207A4CD2-9908-4A66-A6A9-E7EDEE52EA6FQ37677557-B76B7FAC-9F30-4AC0-87F5-66DE4D3565F8Q38294122-56FA8BBF-144F-4816-A7C6-E77B73DE21E7Q38693407-090C1B87-135D-4A0D-92ED-820BFE2DCD44Q38767002-D43E9783-1DA1-4C4B-B853-EC5E046C2811Q39485394-363C1024-FCF8-4D43-8095-AB51311A3C07Q41101605-ED013488-44EB-46CF-A033-C731441CB9EFQ41195724-5F5BBFC5-3B1F-4EDF-8B43-AF9CD0FC385DQ41785590-9DEB42ED-5781-4088-8BCC-FDB6A6DCA18AQ44733776-3B27B8E1-892B-4118-A66A-FEA6ACEBE19A
P2860
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
@en
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
@nl
type
label
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
@en
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
@nl
prefLabel
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
@en
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
@nl
P2093
P50
P1476
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
@en
P2093
Crystal Palmer
Eve Wadsworth
Helen Huang
Kedoudja Nafa
Nandita Mitra
Nathan A Ellis
Tony Gulati
P304
P356
10.1158/1078-0432.CCR-03-0604
P407
P577
2004-05-01T00:00:00Z